Author | David J. Andorsky, MD | OncLive

Author | David J. Andorsky, MD

Articles

Dr. Andorsky on Next Steps Following MAGNIFY Trial in Follicular Lymphoma

August 24, 2017

Video

David J. Andorsky, MD, medical oncology/hematology, Rocky Mountain Cancer Centers, discusses the next steps of the phase IIIb randomized MAGNIFY study of lenalidomide (Revlimid) plus rituximab (Rituxan) followed by maintenance therapy in relapsed/refractory non-Hodgkin lymphoma, focusing on a cohort of patients with follicular lymphoma.

Dr. Andorsky on the MAGNIFY Trial in Follicular Lymphoma

August 03, 2017

Video

David J. Andorsky, MD, medical oncology/hematology, Rocky Mountain Cancer Centers, discusses the phase IIIb randomized MAGNIFY study of lenalidomide (Revlimid) plus rituximab (Rituxan) followed by maintenance therapy in relapsed/refractory non-Hodgkin lymphoma, focusing on a cohort of patients with follicular lymphoma.

x